LifeStance Health Group (LFST) Q1 2024 Earnings
LFST·Reported May 9, 2024·Before market open
LifeStance Health Group reported Q1 2024 revenue of $300.4M, beat analyst consensus of $299.0M by $1.4M. Diluted EPS came in at $-0.06, beat the $-0.09 consensus by $0.03.
Revenue
$300.4Mbeat by $1.4M
Consensus: $299.0MDiluted EPS
$-0.06beat by $0.03
Consensus: $-0.09
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about LifeStance Health Group's Q1 2024 earnings report.
LifeStance Health Group (LFST) reported Q1 2024 earnings on May 9, 2024 before market open.
LifeStance Health Group reported revenue of $300.4M and diluted EPS of $-0.06 for Q1 2024.
Revenue beat the consensus estimate of $299.0M by $1.4M. EPS beat the consensus estimate of $-0.09 by $0.03.
You can read the 10-Q periodic report (0000950170-24-056989) directly on SEC EDGAR. The filing index links above go to sec.gov.